BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
NewCLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic individuals in […]